2024 Fall Conference | C27 - Trigeminal Neuralgia: Mimics, Pharmacotherapy, and Surgical/Interventional Treatment

Date Sunday 10/27/24

Time 09:30 AM - 11:00 AM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Paul G. Mathew, MD, DNBPAS, FAAN, FAHS, FAAN

Topic(s) Headache

Learning Objectives Participants should gain an understanding of the pathophysiology of trigeminal neuralgia and potential neuroanatomical contributions; diagnostic features of trigeminal neuralgia; first- and second-line pharmacologic treatment options for trigeminal neuralgia; therapeutic options for treating breakthrough attacks; the characteristics of odontogenic pain; the differences between TMD and odontogenic pain with trigeminal neuralgia; the role of dentistry and the orofacial pain specialist in a multidisciplinary care model for trigeminal neuralgia; optimal interventional techniques used for the treatment of refractory trigeminal neuralgia; and optimal surgical techniques used for the treatment of trigeminal neuralgia.

CME Available 1.50 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
09:30 AM - 09:55 AM PDT	Speaker	Pathophysiology, Diagnosis, Pharmacological Management of Trigeminal Neuralgia Shamin Masrour, MD
09:55 AM - 10:20 AM PDT	Speaker	Trigeminal Neuralgia Mimics: Headache and Orofacial Pain Differential Diagnosis and Management Marcela Romero-Reyes, DDS, PhD
10:20 AM - 10:45 AM PDT	Speaker	Interventional/Surgical Management of Trigeminal Neuralgia Paul G. Mathew, MD, DNBPAS, FAAN, FAHS, FAAN
10:45 AM - 11:00 AM PDT	Q&A	Questions and Answers Paul G. Mathew, MD, DNBPAS, FAAN, FAHS, FAAN, Shamin Masrour, MD, Marcela Romero-Reyes, DDS, PhD

Faculty Disclosures
Paul G. Mathew, MD, DNBPAS, FAAN, FAHS, FAAN	Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie/Allergan. Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Mathew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven/Pfizer. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Upsher Smith. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie.
Shamin Masrour, MD	Dr. Masrour has nothing to disclose.
Marcela Romero-Reyes, DDS, PhD	Marcela Romero-Reyes, DDS, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Marcela Romero-Reyes, DDS, PhD has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pain Medicine OUP.

��ɫ��

��ɫ��